ACAD
38.15
-0.08
-0.21%
AEMD
0.19
0.00
-2.31%
APRI
2.41
-0.12
-4.75%
ARNA
4.08
-0.2
-4.67%
ATEC
1.52
+0.02
+1.33%
CFN
60.09
-0.11
-0.18%
CNAT
6.35
+0.15
+2.42%
CRXM
0.2
-0.01
-6.62%
CYTX
1.18
+0.06
+5.27%
DXCM
58.98
-0.68
-1.14%
GNMK
12.72
-0.26
-2.00%
HALO
15.22
0.00
0.00%
ILMN
195.97
+1.91
+0.98%
INNV
0.19
+0.02
+8.89%
INO
7.06
-0.11
-1.53%
ISCO
0.06
0.00
-2.11%
ISIS
68.5
+1.7
+2.54%
LGND
66.69
+3.11
+4.89%
LPTN
2.95
+0.01
+0.34%
MBVX
0.93
+0.03
+3.33%
MEIP
5.7
+0.04
+0.71%
MNOV
3.63
+0.09
+2.54%
MRTX
23.66
-0.53
-2.19%
MSTX
0.52
-0.01
-0.96%
NBIX
40.65
+0.22
+0.54%
NUVA
44.21
-0.46
-1.03%
ONCS
0.37
+0.01
+3.04%
ONVO
5.74
-0.01
-0.17%
OREX
7.73
+1.94
+33.44%
OTIC
36.62
+0.24
+0.66%
QDEL
25.82
-0.59
-2.23%
RCPT
125.36
-1.73
-1.36%
RGLS
18.17
-0.4
-2.15%
RMD
64.44
-0.32
-0.49%
SCIE
0.03
0.00
0.00%
SPHS
0.68
-0.06
-8.43%
SRNE
13.25
+0.38
+2.95%
TROV
6.28
+0.23
+3.80%
VICL
0.99
+0.00
+0.01%
VOLC
17.99
0.00
0.00%
ZGNX
1.68
-0.01
-0.59%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.